Literature DB >> 19593223

Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

E F H van Bommel1, I Jansen, T R Hendriksz, A L H J Aarnoudse.   

Abstract

Retroperitoneal fibrosis (RPF) is a rare disorder of unknown etiology. Its incidence is unknown, and the insidious and nonspecific nature of symptoms may contribute to considerable diagnostic delay. We conducted the current study to assess the incidence and clinicoradiologic characteristics of idiopathic RPF. For this, we evaluated prospectively 53 consecutive patients with a diagnosis of idiopathic RPF at our tertiary care referral center from April 1998 through January 2008.Calculated annual incidence of RPF was 1.3/100,000 inhabitants. Mean age was 64 +/- 11.1 (SD) yr; male-female ratio was 3.3:1.0. Median duration of symptoms was 6.0 mo (IQR 3.0-12.0). Abdominal, flank, and/or back pain and discomfort were the major symptoms, with visual analogue scale scores of 49 +/- 27.2 mm and 43 +/- 29.4 mm for pain and discomfort, respectively. Female patients had higher erythrocyte sedimentation rate (ESR), higher white blood cell count, and lower hemoglobin content than male patients at presentation. Computed tomography-documented maximal mass thickness amounted to 35 +/- 16.6 mm; craniocaudal length amounted to 137 +/- 48.8 mm. RPF mass extension up to or above the level of the renal vessels was noted in 3 patients (6%). Six patients (11%) presented with atypical RPF localization and/or bulky mass. Localized lymphadenopathy adjacent to the RPF mass was observed frequently (25%). Patients with hydronephrosis (56%) presented earlier than patients without hydronephrosis, with higher creatinine and greater mass thickness but similar pain severity. Patients were typically at high cardiovascular risk with increased-often aneurysmal-infrarenal aortic diameter (25.0 mm, IQR 22.0-30.0). RPF mass distribution was similar in patients with or without aneurysmal dilation. Occupational asbestos exposure (20%) and asbestos-related pleural changes (17%) were frequent among males. Previous or concurrent chronic inflammatory disease and/or autoimmune disease was noted in 8 patients (15%). Multivariate analysis revealed an independent association of ESR values with severity of pain and discomfort. Smoking was independently associated with infrarenal aortic diameter.In summary, annual RPF incidence is higher than previously assumed. Age at diagnosis and male-female ratio seem to have changed over time. RPF typically affects patients at high cardiovascular risk, including increased aortic diameter. Clinical presentation is influenced by sex, severity of inflammation and presence of hydronephrosis. Prolonged asbestos exposure and asbestos-related pleural changes were frequent among males. Localized lymphadenopathy adjacent to the RPF mass occurs frequently and should not confuse RPF diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593223     DOI: 10.1097/MD.0b013e3181afc420

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  59 in total

1.  [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.

Authors:  Francesco Bertagna; Giorgio Treglia; Lucia Leccisotti; Giovanni Bosio; Federica Motta; Alessandro Giordano; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2012-03-16       Impact factor: 2.374

Review 2.  Chronic Periaortitis: an Update.

Authors:  Alessandra Palmisano; Federica Maritati; Augusto Vaglio
Journal:  Curr Rheumatol Rep       Date:  2018-11-05       Impact factor: 4.592

3.  Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis.

Authors:  Nicholas Haddad; Sero Andonian; Maurice Anidjar
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

4.  [Chronic periaortitis].

Authors:  N Pipitone; C Salvarani; H H Peter
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

Review 5.  Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature.

Authors:  Hang Liu; Gejun Zhang; Yimeng Niu; Nan Jiang; Weiguo Xiao
Journal:  Rheumatol Int       Date:  2014-04-23       Impact factor: 2.631

Review 6. 

Authors:  Nabil Jakhlal; Anouar Elghazoui; Youness Jabbour; Tarik Karmouni; Khalid Elkhader; Abdellatif Koutani; Ahmed Ibenattya
Journal:  Can Urol Assoc J       Date:  2017-01-12       Impact factor: 1.862

Review 7.  Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.

Authors:  Giovanni Maria Rossi; Rossana Rocco; Eugenia Accorsi Buttini; Chiara Marvisi; Augusto Vaglio
Journal:  Intern Emerg Med       Date:  2017-01-09       Impact factor: 3.397

8.  [Subacute lower back pain and acute kidney failure in a 47-year old man].

Authors:  T Tritschler; J Bleisch; A Al Rifai; E Marques Maggio; S Müller; R Schorn
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

9.  Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.

Authors:  E F H van Bommel; L J H van Tits; E A van den Berg; J Prins; A F H Stalenhoef
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

10.  Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of (18)F-FDG-PET/CT and biochemical parameters in patients with renal involvement.

Authors:  Claudia Fofi; Daniela Prosperi; Laura Pettorini; Francescaromana Festuccia; Riccardo Pirisino; Valerio Lanni; Francesco Scopinaro; Giorgio Punzo; Paolo Menè
Journal:  Intern Emerg Med       Date:  2016-03-12       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.